Marvin & Palmer Associates’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Sell
27,070
-30
-0.1% -$4.22K 4.09% 15
2025
Q4
$3.66M Sell
27,100
-2,209
-8% -$295K 2.59% 17
2025
Q3
$4.08M Sell
29,309
-2,417
-8% -$265K 3.04% 12
2025
Q2
$3.13M Buy
+31,726
New +$2.59M 2.69% 17
2023
Q2
Sell
-241,284
Closed -$9.86M 34
2023
Q1
$9.86M Buy
241,284
+55,666
+30% +$2.2M 4.97% 6
2022
Q4
$7.07M Buy
185,618
+2,318
+1% +$87.7K 3.72% 18
2022
Q3
$6.14M Buy
+183,300
New +$6.66M 3.77% 19
2019
Q3
Sell
-136,144
Closed -$3.27M 27
2019
Q2
$3.27M Buy
+136,144
New +$3.28M 2.16% 24
2018
Q4
Sell
-193,820
Closed -$4.56M 28
2018
Q3
$4.56M Buy
193,820
+20,668
+12% +$480K 3.45% 18
2018
Q2
$3.77M Hold
173,152
3.71% 16
2018
Q1
$3.73M Buy
173,152
+20,116
+13% +$453K 3.41% 19
2017
Q4
$3.36M Buy
153,036
+17,008
+13% +$374K 3.48% 13
2017
Q3
$2.88M Sell
136,028
-105,992
-44% -$2.08M 3.53% 13
2017
Q2
$4.47M Buy
242,020
+51,420
+27% +$939K 3.39% 16
2017
Q1
$3.39M Buy
190,600
+47,600
+33% +$824K 2.46% 21
2016
Q4
$2.4M Buy
+143,000
New +$2.38M 2.05% 23
2016
Q1
Sell
-159,300
Closed -$2.09M 49
2015
Q4
$2.09M Sell
159,300
-4,000
-2% -$53.5K 2.14% 23
2015
Q3
$2.08M Sell
163,300
-25,900
-14% -$348K 2.49% 17
2015
Q2
$2.75M Sell
189,200
-1,200
-0.6% -$17.2K 2.6% 15
2015
Q1
$2.81M Buy
190,400
+32,332
+20% +$453K 2.43% 15
2014
Q4
$2.13M Sell
158,068
-452
-0.3% -$5.78K 2.17% 18
2014
Q3
$1.98M Sell
158,520
-52,520
-25% -$659K 2.01% 16
2014
Q2
$2.54M Sell
211,040
-4,800
-2% -$57.2K 2.21% 11
2014
Q1
$2.47M Buy
215,840
+132,640
+159% +$1.48M 2.17% 16
2013
Q4
$927K Buy
83,200
+4,000
+5% +$41.4K 0.56% 57
2013
Q3
$766K Sell
79,200
-28,800
-27% -$281K 0.5% 63
2013
Q2
$1.05M Buy
+108,000
New +$1.03M 0.57% 57

Other funds holding APH

Marvin & Palmer Associates's APH Position: Q1 2026 in Review

Marvin & Palmer Associates reduced its Amphenol (APH) stake by 0.11% in Q1 2026, selling an estimated $4.22K and leaving 27,070 shares worth $3.42M. The position accounts for 4.09% of the portfolio, ranked #15.

Marvin & Palmer Associates first reported a position in APH in Q2 2013 and has held it in 27 quarters since. The position peaked at $9.86M in Q1 2023. 2,116 funds tracked by Wall St. Rank hold APH as of Q1 2026.

  • Marvin & Palmer Associates held 27,070 shares of Amphenol worth $3.42M as of Q1 2026.
  • Marvin & Palmer Associates sold 30 Amphenol shares in Q1 2026, an estimated $4.22K.
  • Amphenol made up 4.09% of Marvin & Palmer Associates's portfolio in Q1 2026, its #15 holding.
  • Marvin & Palmer Associates first reported a position in Amphenol in Q2 2013 and has held it in 27 quarters since.
  • Marvin & Palmer Associates's Amphenol position peaked at $9.86M in Q1 2023.
  • 2,116 funds tracked by Wall St. Rank held Amphenol as of Q1 2026.

Based on Marvin & Palmer Associates's 13F filing for Q1 2026, filed 8 May 2026.